Immunoaffinity enrichments followed by mass spectrometric detection for studying global protein tyrosine

Sara Bergström Lind1, Magnus Molin, Mikhail M Savitski

  • 1Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-751 85 Uppsala, Sweden. Sara.Lind@genpat.uu.se

Insights

This study evaluated anti-phosphotyrosine antibodies for enriching low-abundance tyrosine phosphorylated (P-Tyr) proteins in leukemia cells. Combining antibody enrichment of both proteins and peptides identified 40 true P-Tyr proteins, crucial for understanding cell signaling and oncogenesis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Proteomics

Background:

  • Protein tyrosine phosphorylation is critical for cell function and implicated in cancer.
  • Identifying tyrosine phosphorylated (P-Tyr) proteins requires highly selective enrichment due to their low cellular abundance.
  • Developing robust methods for P-Tyr protein detection is essential for biological and medical research.

Purpose of the Study:

  • To evaluate and compare the efficacy of five anti-phosphotyrosine antibodies for immunoaffinity enrichment of P-Tyr proteins.
  • To identify and accurately characterize P-Tyr proteins and their phosphorylation sites in K562 leukemia cell extracts.
  • To determine the optimal strategy for P-Tyr protein enrichment and identification using mass spectrometry.

Main Methods:

  • Immunoaffinity enrichment of P-Tyr proteins and peptides using five different anti-phosphotyrosine antibodies (4G10, PY100, PYKD1, 13F9, and a polyclonal antiserum).
  • Analysis of enriched samples using liquid chromatography Fourier transform mass spectrometry (LC-FTMS) with complementary collision-activated dissociation (CAD) and electron capture dissociation (ECD) fragmentations.
  • Comparative evaluation of protein-level versus peptide-level enrichment strategies for P-Tyr protein identification.

Main Results:

  • Antibodies 4G10 and PY100 showed the highest capability in initial screening for putative P-Tyr proteins.
  • Protein-level enrichment with the 4G10 antibody identified 459 putative P-Tyr proteins, with 12 directly verified.
  • Peptide-level enrichment with the PY100 antibody detected 67 P-Tyr sites and 89 putative P-Tyr proteins; protein identification was less reliable.
  • A combined approach identified 40 true P-Tyr proteins in K562 cell line extracts.

Conclusions:

  • No single antibody or enrichment strategy is sufficient for comprehensive P-Tyr protein profiling.
  • Combining immunoaffinity enrichment using multiple antibodies with both intact and digested proteins is necessary for maximal coverage.
  • This optimized approach enhances the identification of P-Tyr proteins, aiding research into cell signaling and oncogenesis.